MAM
RCKT icon

Monaco Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Monaco Asset Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.48M Buy
2,480,468
+422,165
+21% +$1.4M 0.67% 23
2026
Q1 		$7.37M Sell
2,058,303
-928,993
-31% -$3.69M 1.36% 22
2025
Q4 		$10.5M Buy
2,987,296
+95,035
+3% +$325K 1.82% 17
2025
Q3 		$9.43M Buy
2,892,261
+2,439,494
+539% +$7.68M 0.57% 20
2025
Q2 		$1.11M Buy
+452,767
New +$2.29M 0.19% 62

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Monaco Asset Management's RCKT Position: Q2 2026 in Review

Monaco Asset Management increased its Rocket Pharmaceuticals (RCKT) stake by 21% in Q2 2026, buying an estimated $1.4M and bringing the position to 2,480,468 shares worth $8.48M. The position accounts for 0.67% of the portfolio, ranked #23.

Monaco Asset Management first reported a position in RCKT in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.5M in Q4 2025. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Monaco Asset Management held 2,480,468 shares of Rocket Pharmaceuticals worth $8.48M as of Q2 2026.
  • Monaco Asset Management bought 422,165 Rocket Pharmaceuticals shares in Q2 2026, an estimated $1.4M.
  • Rocket Pharmaceuticals made up 0.67% of Monaco Asset Management's portfolio in Q2 2026, its #23 holding.
  • Monaco Asset Management first reported a position in Rocket Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Monaco Asset Management's Rocket Pharmaceuticals position peaked at $10.5M in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Monaco Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.